Publication | Closed Access
Seizure management in acute hepatic porphyria
87
Citations
0
References
1980
Year
HepatologyMedicineAcute Hepatic PorphyriasClinical PharmacologyToxicologyAcute Liver FailurePharmacotherapyExperimental PharmacologyDrug TherapySeizure ManagementHepatotoxicityPharmacologyPharmacokineticsAcute Intermittent PorphyriaPorphyriasSeizure Disorder
Seizures may occur in acute intermittent porphyria or other hepatic porphyrias. Management is difficult, because barbiturates and hydantoins exacerbate the porphyric state. We studied one patient with major motor seizures and acute intermittent porphyria. The seizure disorder was exacerbated by phenytoin and did not respond to a high-carbohydrate diet or to intravenous hematin. Clonazepam was ineffective in treating the seizures and, in high doses, seemed to exacerbate the porphyria. Both clonazepam and valproate were porphyrinogenic in experimental test systems. Because both drugs may exacerbate the acute hepatic porphyrias, bromide remains the drug of choice to treat these seizures.